HB2157 — Expanding pharmacist's scope of practice to include point-of-care testing for and treatment of COVID-19.

HB2157 — Expanding pharmacist's scope of practice to include point-of-care testing for and treatment of COVID-19. · Informed CitizenryThis bill amends K.S.A. 2024 Supp. 65-16,131 to allow a pharmacist to initiate therapy for Influenza, streptococcal pharyngitis, urinary tract infection, or COVID-19, provided the therapy is within…Open in Informed Citizenry